LV11469B - 5-vinyl- and 5-ethynyl-quinolonyl- and naphthyridinyl-carboxylic - Google Patents
5-vinyl- and 5-ethynyl-quinolonyl- and naphthyridinyl-carboxylic Download PDFInfo
- Publication number
- LV11469B LV11469B LVP-95-48A LV950048A LV11469B LV 11469 B LV11469 B LV 11469B LV 950048 A LV950048 A LV 950048A LV 11469 B LV11469 B LV 11469B
- Authority
- LV
- Latvia
- Prior art keywords
- methyl
- hydrogen
- oxo
- alkyl
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/762—Organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/771—Organic compounds containing hetero rings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Animal Husbandry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4408212A DE4408212A1 (de) | 1994-03-11 | 1994-03-11 | 5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV11469A LV11469A (lv) | 1996-08-20 |
| LV11469B true LV11469B (en) | 1996-12-20 |
Family
ID=6512492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-95-48A LV11469B (en) | 1994-03-11 | 1995-03-10 | 5-vinyl- and 5-ethynyl-quinolonyl- and naphthyridinyl-carboxylic |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US5578604A (fr) |
| EP (1) | EP0671391A1 (fr) |
| JP (1) | JPH07285941A (fr) |
| KR (1) | KR950032177A (fr) |
| CN (1) | CN1111629A (fr) |
| AU (1) | AU689189B2 (fr) |
| BG (1) | BG62001B1 (fr) |
| CA (1) | CA2144231A1 (fr) |
| CO (1) | CO4340737A1 (fr) |
| CZ (1) | CZ63895A3 (fr) |
| DE (1) | DE4408212A1 (fr) |
| DZ (1) | DZ1862A1 (fr) |
| EE (1) | EE9500020A (fr) |
| FI (1) | FI951101A7 (fr) |
| HR (1) | HRP950077A2 (fr) |
| HU (1) | HUT72071A (fr) |
| IL (1) | IL112936A0 (fr) |
| LV (1) | LV11469B (fr) |
| MA (1) | MA23475A1 (fr) |
| NO (1) | NO950936L (fr) |
| NZ (1) | NZ270657A (fr) |
| PE (1) | PE33895A1 (fr) |
| PL (1) | PL307583A1 (fr) |
| RU (1) | RU95103433A (fr) |
| SK (1) | SK31695A3 (fr) |
| SV (1) | SV1995000012A (fr) |
| TN (1) | TNSN95017A1 (fr) |
| YU (1) | YU15895A (fr) |
| ZA (1) | ZA952008B (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4230804A1 (de) * | 1992-09-15 | 1994-03-17 | Bayer Ag | 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate |
| DE4427530A1 (de) * | 1994-08-04 | 1996-02-08 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| US6025154A (en) | 1995-06-06 | 2000-02-15 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 |
| US6743594B1 (en) | 1995-06-06 | 2004-06-01 | Human Genome Sciences, Inc. | Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) |
| DE19652219A1 (de) | 1996-12-16 | 1998-06-18 | Bayer Ag | Verwendung von 7-(1-Aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl)-chinolon- und naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen |
| US6984499B2 (en) * | 1997-10-02 | 2006-01-10 | Idexx Laboratories, Inc. | Method and apparatus for concurrently detecting pathogenic organisms and antimicrobial susceptibility |
| MXPA02005884A (es) | 1999-12-14 | 2002-10-23 | Neurosearch As | Heteroaril-diazabicicloalcanos novedosos. |
| US7175988B2 (en) | 2001-02-09 | 2007-02-13 | Human Genome Sciences, Inc. | Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
| WO2002096911A1 (fr) * | 2001-06-01 | 2002-12-05 | Neurosearch A/S | Nouveaux heteroaryl-diazabicyclo-alcanes a titre de modulateurs du snc |
| US7282344B2 (en) * | 2001-06-06 | 2007-10-16 | Neurosearch A/S | Cation conducting GABAA receptors and their use |
| US7393934B2 (en) | 2001-12-21 | 2008-07-01 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor (CCR5) HDGNR10 |
| CN100410249C (zh) | 2003-09-10 | 2008-08-13 | 杏林制药株式会社 | 7-(4-取代-3-环丙基氨基甲基-1-吡咯烷基)喹诺酮羧酸衍生物 |
| WO2005105841A2 (fr) | 2004-03-12 | 2005-11-10 | Human Genome Sciences, Inc. | Récepteur humain (ccr5) hdgnr10 de chimiokine de la protéine g |
| CA2688008A1 (fr) | 2007-05-24 | 2008-11-27 | Kyorin Pharmaceutical Co., Ltd. | Derive de la mutiline ayant une structure d'acide carboxylique a noyau aromatique heterocyclique en substituant a la position 14 |
| CN103724262B (zh) * | 2013-12-10 | 2016-05-18 | 广东省第二人民医院 | 一种氟喹诺酮银化合物及其制备方法和用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5563138A (en) * | 1987-04-16 | 1996-10-08 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds |
| EP0319906A3 (fr) * | 1987-12-11 | 1990-05-02 | Dainippon Pharmaceutical Co., Ltd. | Dérivés de la quinoléine, procédé de leur préparation et agent antibactérien les contenant |
| US4920120A (en) * | 1988-01-25 | 1990-04-24 | Warner-Lambert Company | Antibacterial agents |
| AU5123690A (en) * | 1989-03-13 | 1990-09-13 | Bristol-Myers Squibb Company | 5-substituted-1,4-dihydro-4-oxo-nephthyridine-3-carboxylate antibacterial agents |
| DE3910663A1 (de) * | 1989-04-03 | 1990-10-04 | Bayer Ag | 5-alkylchinoloncarbonsaeuren |
| US5252734A (en) * | 1989-04-03 | 1993-10-12 | Bayer Aktiengesellschaft | Antibacterial 5-alkylquinolonecarboxylic acids |
| US5140033A (en) * | 1989-04-03 | 1992-08-18 | Bayer Aktiengesellschaft | Antibacterial 5-alkylquinolonecarboxylic acids |
| US5696132A (en) * | 1991-05-28 | 1997-12-09 | Daiichi Pharmaceutical Co., Ltd. | Pyridonecarboxylic acid derivatives |
-
1994
- 1994-03-11 DE DE4408212A patent/DE4408212A1/de not_active Withdrawn
-
1995
- 1995-02-20 HR HRP4408212.6A patent/HRP950077A2/hr not_active Application Discontinuation
- 1995-02-27 EP EP95102762A patent/EP0671391A1/fr not_active Withdrawn
- 1995-03-03 US US08/398,328 patent/US5578604A/en not_active Expired - Fee Related
- 1995-03-06 CO CO95008716A patent/CO4340737A1/es unknown
- 1995-03-06 DZ DZ950026A patent/DZ1862A1/fr active
- 1995-03-06 AU AU13649/95A patent/AU689189B2/en not_active Ceased
- 1995-03-06 PE PE1995263451A patent/PE33895A1/es not_active Application Discontinuation
- 1995-03-08 EE EE9500020A patent/EE9500020A/xx unknown
- 1995-03-08 IL IL11293695A patent/IL112936A0/xx unknown
- 1995-03-08 NZ NZ270657A patent/NZ270657A/en unknown
- 1995-03-08 YU YU15895A patent/YU15895A/sh unknown
- 1995-03-08 PL PL95307583A patent/PL307583A1/xx unknown
- 1995-03-08 CA CA002144231A patent/CA2144231A1/fr not_active Abandoned
- 1995-03-09 BG BG99490A patent/BG62001B1/bg unknown
- 1995-03-09 TN TNTNSN95017A patent/TNSN95017A1/fr unknown
- 1995-03-09 JP JP7077134A patent/JPH07285941A/ja active Pending
- 1995-03-09 FI FI951101A patent/FI951101A7/fi unknown
- 1995-03-10 HU HU9500728A patent/HUT72071A/hu unknown
- 1995-03-10 RU RU95103433/04A patent/RU95103433A/ru unknown
- 1995-03-10 CN CN95102213A patent/CN1111629A/zh active Pending
- 1995-03-10 CZ CZ95638A patent/CZ63895A3/cs unknown
- 1995-03-10 KR KR1019950004888A patent/KR950032177A/ko not_active Withdrawn
- 1995-03-10 MA MA23803A patent/MA23475A1/fr unknown
- 1995-03-10 ZA ZA952008A patent/ZA952008B/xx unknown
- 1995-03-10 LV LVP-95-48A patent/LV11469B/lv unknown
- 1995-03-10 SV SV1995000012A patent/SV1995000012A/es unknown
- 1995-03-10 SK SK316-95A patent/SK31695A3/sk unknown
- 1995-03-10 NO NO950936A patent/NO950936L/no unknown
-
1996
- 1996-05-03 US US08/642,662 patent/US5659038A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0350733B1 (fr) | Dérivés d'acides 7-(1-pyrrolidinyl)-3-quinolone et -naphtyridone carboxyliques, procédé pour leur préparation | |
| DE69015239T2 (de) | Chinolinon-Derivate, Verfahren zu ihrer Herstellung und diese Derivate enthaltende antibakteriell wirkende Mittel. | |
| DE60021630T2 (de) | Tricyclische kondensierte heterocyclische Verbindungen als CRF Antagonisten | |
| LV11469B (en) | 5-vinyl- and 5-ethynyl-quinolonyl- and naphthyridinyl-carboxylic | |
| AT389698B (de) | Verfahren zur herstellung von neuen 1,4-dihydro-4-oxonaphthyridin-derivaten und deren salzen | |
| EP0489458B1 (fr) | Dérivés d'hydroxychinolone | |
| DE60210067T2 (de) | Tricyklische diazepine als tocolytische oxytocinrezeptor-antagonisten | |
| EP0523512B1 (fr) | Acides quinolone-carboxyliques-vinyl-8 et -éthinyl-8 | |
| JPH05508868A (ja) | キノリン、ナフチリジンおよびピリドベンゾキサジン誘導体 | |
| DD228256A5 (de) | Verfahren zur herstellung von 1,8-naphthyridinderivaten | |
| WO2003020722A1 (fr) | Nouvelles dihydropteridinones, procedes pour les produire et leur utilisation en tant que medicaments | |
| DE4120646A1 (de) | 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate | |
| DD274029A5 (de) | Verfahren zur herstellung 5-substituierter chinolon- und naphthyridoncarbonsaeure-derivate | |
| DD298400A5 (de) | 5-alkylchinoloncarbonsaeuren | |
| EP0259804A2 (fr) | Dérivés de pyrido[3,2,1-ij]-1,3,4-benzoxadiazine, leur procédé de préparation, compositions pharmaceutiques correspondantes et intermédiaires utilisables dans le procédé | |
| EP0607825A1 (fr) | Acides 6-H-4-OXO-3-quinoléine-carboxyliques et leurs analoques comme agents antibactériens | |
| DE60310767T2 (de) | PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN | |
| DE3934082A1 (de) | Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel | |
| DE3835842A1 (de) | Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| EP0187376A2 (fr) | Acides 6,7-disubstitués 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphtyridine-3-carboxyliques | |
| DE60204582T2 (de) | Neue heteroaromatische amidderivate von 3beta aminoazabicyclooctanen, verfahren zu ihrer herstellung und ihre therapeutische verwendung | |
| DD295375A5 (de) | Pyridinyl-chinolon-verbindungen, ihre herstellung und verwendung | |
| EP0589318B1 (fr) | Dérivés antibactériens d'acides de 7-(aminométhyl-oxa-7-azabicyclo(3.3.0)oct-7-yl)quinolone- et -naphthyridone-carboxyliques | |
| LV11328B (en) | Derivatives of 1-(2-fluorcyclopropyl)-quinolone and naphthyridine carbonic acids | |
| EP0704443B1 (fr) | Dérivés de l'acide quinolone et naphthyridonecarboxylique |